Inventia Recalls 25,027 Chlorthalidone Bottles Nationwide
Inventia Healthcare has recalled more than 25,000 bottles of 25-milligram chlorthalidone, a blood-pressure medication, after tests found the tablets failed dissolution standards, potentially affecting how the drug is absorbed. The FDA classified the recalls as Class II; patients should consult a doctor or pharmacist before changing or stopping their medication.
Health · 6 sources · 4dRead itThe journal
Open the journal →The conversation starts in the journal — be the first to post.
About chlorthalidone
Chlortalidone, also known as chlorthalidone, is a thiazide-like diuretic drug used to treat high blood pressure, swelling, diabetes insipidus, and renal tubular acidosis. Because chlortalidone is effective in most patients with high blood pressure, it is considered a preferred initial treatment. It is also used to prevent calcium-based kidney stones. It is taken by mouth. Effects generally begin within three hours and last for up to three days. Long-term treatment with chlortalidone is more effective than hydrochlorothiazide for prevention of heart attack or stroke.
Everything about chlorthalidone →